Medstudio
Medstudio
Stealth ModeMedstudio is an AI-powered platform that transforms medical imaging data into interactive 3D models for enhanced surgical planning and patient education.
About
What does Medstudio do?
Medstudio develops an AI-driven platform that converts 2D medical images (like CT and MRI scans) into detailed, interactive 3D anatomical models. This technology aids surgeons in pre-operative planning by providing a comprehensive spatial understanding of patient anatomy and improves patient comprehension through visual, personalized explanations of their conditions and procedures.
What industry does Medstudio operate in?
Medstudio operates in MedTech, HealthTech, Surgical Planning, Medical Imaging, 3D Modeling, Computer Vision.
What is Medstudio's current status?
Medstudio's current operating status is: Inactive.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
AI-powered digital health platform offering personalized nutrition and wellness plans based on individual metabolism.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.